Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

UnitedHealth Group Incorporated (UNH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

UNH

NEW YORK CITY, NY / ACCESS Newswire / May 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH). Investors who purchased UnitedHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/UNH.


Investigation Details

On April 17, 2025, The Wall Street Journal published an article entitled "UnitedHealth Shares Tumble After Earnings Fall Short Due to Medicare Issues." The article stated that UnitedHealth stock fell after "earnings fell short of Wall Street's expectations, and the healthcare company substantially downgraded its projected results for 2025, citing problems in its Medicare business." Following this news, UnitedHealth stock dropped $130.93 per share, or 22.3%, to close at $454.11 on April 17, 2025.

What's Next?

If you are aware of any facts relating to this investigation or purchased UnitedHealth securities, you can assist this investigation by visiting the firm's site: bgandg.com/UNH. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View the original press release on ACCESS Newswire



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today